A comparison of progestogen-only injectable contraceptives
Keywords: progestogen-only injectable contraceptives, POICs, DMPA, NET-EN, Petogen®, Depo-Prover®, Nur-Isterate®
AbstractProgestogen-only injectable contraceptives (POICs) are slow-release reversible preparations that last for 2-3 months. Two are available in South Africa, namely depot medroxyprogesterone acetate (DMPA), marketed as Petogen® and Depo-Provera® (Schedule 4), and norethisterone enantate (NET-EN), marketed as Nur-Isterate® (Schedule 4). They provide safe, convenient and acceptable contraception with high use-effectiveness. An overview of the similarities and differences between DMPA and NET-EN are outlined in order for practitioners to assist women in the selection of an acceptable POIC. Particular information on bleeding profiles, managing overdue injections and controlling breakthrough bleeding is outlined. Recommendations are given for adolescents and older women. The POIC effects on certain diseases are discussed.
By submitting manuscripts to PNT, authors of original articles are assigning copyright to Medpharm Publications (Pty) Ltd. Authors may use their own work after publication without written permission, provided they acknowledge the original source. Individuals and academic institutions may freely copy and distribute articles published in PNT for educational and research purposes without obtaining permission.